Revolution Medicines, Inc. (RVMD) vs Vertex Pharmaceuticals Incorporated (VRTX)
- Revolution Medicines, Inc. RVMD 192.46 +8.34%
- Vertex Pharmaceuticals Incorporated VRTX 546.45 +0.73%
Revolution Medicines, Inc. and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $137.5B against $38.1B — 3.6× the size. Revolution Medicines, Inc. has negative trailing earnings, so its P/E is not meaningful; Vertex Pharmaceuticals Incorporated trades at 34.6×. Revolution Medicines, Inc. grew revenue faster over the last twelve months: 491.1% against 10.5%. Vertex Pharmaceuticals Incorporated has the higher net margin (30.7% vs −894.4%) and the higher return on invested capital (14.9% vs 0.00%). Across the 19 metrics below, Vertex Pharmaceuticals Incorporated leads on 15 and Revolution Medicines, Inc. on 4.
Valuation
Profitability
| Metric | RVMD | VRTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.62% | 85.53% | 65.16% |
| Operating margin | (805.75%) | 33.23% | 0.00% |
| Net margin | (894.40%) | 30.70% | 0.00% |
| Free cash flow margin | (688.93%) | 24.73% | 0.00% |
| Return on equity | (93.56%) | 20.80% | (50.12%) |
| Return on assets | (57.07%) | 13.81% | (45.60%) |
| Return on invested capital | 0.00% | 14.86% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack